This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Bebetter Med Inc., Guangzhou Bebetter Medicine Technology Co., Ltd.. Active years: 2019-2022.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2019-2022
Title: Innovations by Yuanhui Qing in Medicinal Chemistry
Introduction
Yuanhui Qing is a notable inventor based in Guangdong, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific cancer-related pathways. With a total of 2 patents, his work focuses on innovative solutions for treating tumors, especially those associated with mutant epidermal growth factor receptors (EGFR).
Latest Patents
Yuanhui Qing's latest patents include a 2,4-bis(nitrogen-containing group)-substituted pyrimidine compound and a pyrimidine or pyridopyridone compound. The first patent describes a compound that selectively suppresses the activity of mutant EGFR, including the T790M mutation, which is crucial for developing anti-tumor drugs. This compound shows a high selectivity for mutant receptors while having a weak effect on wild-type EGFR, making it a promising candidate for treating non-small cell lung cancer (NSCLC). The second patent focuses on a compound that selectively inhibits cyclin-dependent kinases CDK4 and CDK6, which are involved in cell cycle control disorders. This compound has potential applications in treating various malignant tumors.
Career Highlights
Throughout his career, Yuanhui Qing has worked with several companies, including Bebetter Med Inc. and Guangzhou Bebetter Medicine Technology Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medicinal products.
Collaborations
Yuanhui Qing has collaborated with notable colleagues such as Weicai Xue and Xiong Cai. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions in the field of medicinal chemistry.
Conclusion
Yuanhui Qing's innovative work in developing targeted therapies for cancer demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of cancer treatment and hold promise for future therapeutic applications.